NCBI PubMed Central
open access
Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer#1282238
- Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma#800269
- Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer#807175
- Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer#978908
- Cancer statistics in China, 2015#6836
Record · ID 1538298
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive